Biosimilars, Biosimilars and Biologics, Biotechnology Patents, Industry News - Technology, Business and Law, patent attorney india, Patent Lawyer Patent Attorney Consulting, Pharmaceutical Patents

Regulatory Challenges and FDA Approval of Biosimilars – An Overview

Biosimilars are generic versions of biologics, medicinal products with active drug component being made (or derived) from a living organism. It is complicated and cost intensive to manufacture biologics, and hence regulatory approval of biosimilars is very challenging.

Originally published here.

biosimilar biotech patent attorney

About the Author: Rahul Dev

Advice for Contacting

Engagements: Contractual Consulting, Hourly, Project Based

Contact Mode: LinkedIn or directly message here

Schedule a Consultation Now

Ask a General Question

Previous Blog Posts on Web

Previous Blog Posts on Twitter

!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);;js.src=p+”://”;fjs.parentNode.insertBefore(js,fjs);}}(document,”script”,”twitter-wjs”);
This is not a legal advice: Disclaimer, Non-Solicitation & Liability
Visit Technology Law Business Blog’s profile on Pinterest.//